GSK gene therapy deal

Orchard Therapeutics Ltd has come closer to its goal of becoming a global supplier of gene therapies following an agreement with GlaxoSmithKline Plc to take over that company’s portfolio of gene therapies for rare diseases.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom